Spectrum of Small Mutations in the Dystrophin Coding Region

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 1995 Jul 1

PMID 7611292

Citations 22

Authors

T W Prior

C Bartolo

D K Pearl

A C Papp

P J Snyder

M S Sedra

A H Burghes

J R Mendell

Affiliations

Soon will be listed here.

Abstract

Duchenne and Becker muscular dystrophies (DMD and BMD) are caused by defects in the dystrophin gene. About two-thirds of the affected patients have large deletions or duplications, which occur in the 5' and central portion of the gene. The nondeletion/duplication cases are most likely the result of smaller mutations that cannot be identified by current diagnostic screening strategies. We screened approximately 80% of the dystrophin coding sequence for small mutations in 158 patients without deletions or duplications and identified 29 mutations. The study indicates that many of the DMD and the majority of the BMD small mutations lie in noncoding regions of the gene. All of the mutations identified were unique to single patients, and most of the mutations resulted in protein truncation. We did not find a clustering of small mutations similar to the deletion distribution but found > 40% of the small mutations 3' of exon 55. The extent of protein truncation caused by the 3' mutations did not determine the phenotype, since even the exon 76 nonsense mutation resulted in the severe DMD phenotype. Our study confirms that the dystrophin gene is subject to a high rate of mutation in CpG sequences. As a consequence of not finding any hotspots or prevalent small mutations, we conclude that it is presently not possible to perform direct carrier and prenatal diagnostics for many families without deletions or duplications.

Citing Articles

Natural history of Becker muscular dystrophy: a multicenter study of 225 patients.

Nakamura A, Matsumura T, Ogata K, Mori-Yoshimura M, Takeshita E, Kimura K Ann Clin Transl Neurol. 2023; 10(12):2360-2372.

PMID: 37882106 PMC: 10723226. DOI: 10.1002/acn3.51925.

NGS-based targeted sequencing identified six novel variants in patients with Duchenne/Becker muscular dystrophy from southwestern China.

Tang F, Xiao Y, Zhou C, Zhang H, Wang J, Zeng Y BMC Med Genomics. 2023; 16(1):121.

PMID: 37254189 PMC: 10228078. DOI: 10.1186/s12920-023-01556-1.

Specificities of the DMD Gene Mutation Spectrum in Russian Patients.

Zinina E, Bulakh M, Chukhrova A, Ryzhkova O, Sparber P, Shchagina O Int J Mol Sci. 2022; 23(21).

PMID: 36361501 PMC: 9658738. DOI: 10.3390/ijms232112710.

Morpholino Oligomer-Induced Dystrophin Isoforms to Map the Functional Domains in the Dystrophin Protein.

Li D, Adams A, Johnsen R, Fletcher S, Wilton S Mol Ther Nucleic Acids. 2020; 22:263-272.

PMID: 33230432 PMC: 7516190. DOI: 10.1016/j.omtn.2020.08.019.

Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride.

Takizawa H, Hara Y, Mizobe Y, Ohno T, Suzuki S, Inoue K Sci Rep. 2019; 9(1):3807.

PMID: 30846748 PMC: 6405839. DOI: 10.1038/s41598-019-40421-z.

References

Saad F, Busque C, Vitiello L, Danieli G . DXS997 localized to intron 48 of dystrophin. Hum Mol Genet. 1993; 2(12):2199. DOI: 10.1093/hmg/2.12.2199. View

Baserga S, Benz Jr E . Beta-globin nonsense mutation: deficient accumulation of mRNA occurs despite normal cytoplasmic stability. Proc Natl Acad Sci U S A. 1992; 89(7):2935-9. PMC: 48778. DOI: 10.1073/pnas.89.7.2935. View

Klein C, Coovert D, Bulman D, Ray P, Mendell J, Burghes A . Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet. 1992; 50(5):950-9. PMC: 1682584. View

Kilimann M, Pizzuti A, Grompe M, Caskey C . Point mutations and polymorphisms in the human dystrophin gene identified in genomic DNA sequences amplified by multiplex PCR. Hum Genet. 1992; 89(3):253-8. DOI: 10.1007/BF00220535. View

Mashima Y, Murakami A, Weleber R, Kennaway N, Clarke L, Shiono T . Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. Am J Hum Genet. 1992; 51(1):81-91. PMC: 1682884. View

Bies R, Caskey C, Fenwick R . An intact cysteine-rich domain is required for dystrophin function. J Clin Invest. 1992; 90(2):666-72. PMC: 443149. DOI: 10.1172/JCI115909. View

Roberts R, Coffey A, Bobrow M, Bentley D . Determination of the exon structure of the distal portion of the dystrophin gene by vectorette PCR. Genomics. 1992; 13(4):942-50. DOI: 10.1016/0888-7543(92)90005-d. View

Belgrader P, Cheng J, Maquat L . Evidence to implicate translation by ribosomes in the mechanism by which nonsense codons reduce the nuclear level of human triosephosphate isomerase mRNA. Proc Natl Acad Sci U S A. 1993; 90(2):482-6. PMC: 45687. DOI: 10.1073/pnas.90.2.482. View

Soto D, Sukumar S . Improved detection of mutations in the p53 gene in human tumors as single-stranded conformation polymorphs and double-stranded heteroduplex DNA. PCR Methods Appl. 1992; 2(1):96-8. DOI: 10.1101/gr.2.1.96. View

10.

Winnard A, Gibbs R, Mendell J, Burghes A . Identification of a 2 base pair nonsense mutation causing a cryptic splice site in a DMD patient. Hum Mol Genet. 1992; 1(8):645-6. DOI: 10.1093/hmg/1.8.645. View

11.

Roberts R, Passos-Bueno M, Bobrow M, Vainzof M, Zatz M . Point mutation in a Becker muscular dystrophy patient. Hum Mol Genet. 1993; 2(1):75-7. DOI: 10.1093/hmg/2.1.75. View

12.

Youssoufian H, Kazazian Jr H, Phillips D, Aronis S, Tsiftis G, Brown V . Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots. Nature. 1986; 324(6095):380-2. DOI: 10.1038/324380a0. View

13.

Koenig M, Monaco A, Kunkel L . The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988; 53(2):219-28. DOI: 10.1016/0092-8674(88)90383-2. View

14.

Monaco A, Bertelson C, Moser H, Kunkel L . An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988; 2(1):90-5. DOI: 10.1016/0888-7543(88)90113-9. View

15.

Forrest S, Cross G, Flint T, Speer A, Robson K, Davies K . Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Genomics. 1988; 2(2):109-14. DOI: 10.1016/0888-7543(88)90091-2. View

16.

Malhotra S, Hart K, Klamut H, Thomas N, Bodrug S, Burghes A . Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science. 1988; 242(4879):755-9. DOI: 10.1126/science.3055295. View

17.

Chamberlain J, Gibbs R, Ranier J, Nguyen P, Caskey C . Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988; 16(23):11141-56. PMC: 339001. DOI: 10.1093/nar/16.23.11141. View

18.

McCabe E, Towbin J, Chamberlain J, Baumbach L, Witkowski J, van Ommen G . Complementary DNA probes for the Duchenne muscular dystrophy locus demonstrate a previously undetectable deletion in a patient with dystrophic myopathy, glycerol kinase deficiency, and congenital adrenal hypoplasia. J Clin Invest. 1989; 83(1):95-9. PMC: 303648. DOI: 10.1172/JCI113890. View

19.

Campbell K, Kahl S . Association of dystrophin and an integral membrane glycoprotein. Nature. 1989; 338(6212):259-62. DOI: 10.1038/338259a0. View

20.

Urlaub G, Mitchell P, Ciudad C, Chasin L . Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Mol Cell Biol. 1989; 9(7):2868-80. PMC: 362753. DOI: 10.1128/mcb.9.7.2868-2880.1989. View